Baluran, Merlyn N.
HRN: 24-42-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/14/2024
07/21/2024
IV
600mg
Q8
Non Healing Wound
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes